Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter Study

Dino Amadori, Annalisa Volpi, A. Tienghi et al.|Journal of Clinical Oncology|2000

Cited by 58